# Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection

> **NCT02647983** · PHASE1 · WITHDRAWN · sponsor: **Sunnybrook Health Sciences Centre**

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **DRUG:** Hyperpolarized Pyruvate (13C) Injection

## Key facts

- **NCT ID:** NCT02647983
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-04
- **Primary completion:** 2019-10
- **Final completion:** 2019-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of participants
- **Last updated:** 2020-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02647983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02647983, "Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02647983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*